How DICER Cuts microRNAs with Single-Nucleotide Precision

Why It Matters

Understanding DICER’s exact cutting mechanism enables more precise gene‑silencing tools and sheds light on disease pathways linked to miRNA dysregulation.

Key Takeaways

• DICER uses dual 5′‑end binding pockets for precision
• Cryo‑EM reveals atomic‑level conformational adjustments before cleavage
• Newly identified G‑favored pocket expands known U‑pocket model
• Findings inform design of more accurate RNA therapeutics
• Mis‑cleavage linked to cancers, immune and genetic disorders

Pulse Analysis

RNA interference hinges on the accurate processing of microRNA precursors, a task performed by the ribonuclease DICER. By trimming double‑stranded RNA into ~22‑nucleotide fragments, DICER supplies the guide strands that steer the RNA‑induced silencing complex to target messenger RNAs. Precise cleavage is essential; even a single‑nucleotide shift can alter target specificity, leading to off‑target effects or loss of regulation. The enzyme’s evolutionary conservation underscores its central role in gene expression, development, and cellular homeostasis, making any mechanistic insight highly valuable for both basic biology and clinical applications.

In the new Nature paper, the HKUST team combined cryo‑electron microscopy with biochemical assays to capture DICER in multiple functional states. They discovered that the enzyme possesses two distinct 5′‑end binding pockets: a previously known uridine‑preferring pocket and a novel guanosine‑preferring pocket. These pockets act as molecular guides, positioning the RNA substrate so that the catalytic core cleaves at the exact nucleotide. Structural snapshots revealed conformational shifts that align the RNA motif with the catalytic site, providing a clear atomic‑level explanation for DICER’s fidelity across varied precursor sequences.

The implications extend beyond academic curiosity. Precise knowledge of DICER’s cleavage rules can be leveraged to engineer synthetic miRNA mimics and small interfering RNAs with predictable outcomes, reducing unintended gene silencing. Moreover, mutations that disrupt pocket interactions may underlie certain cancers, immune disorders, and genetic diseases linked to miRNA dysregulation. By mapping these mechanistic details, researchers can design therapeutic interventions—such as pocket‑targeted small molecules or engineered DICER variants—to restore normal miRNA processing, opening new avenues in personalized medicine.